Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04623008
Other study ID # 2019H0441
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 1, 2021
Est. completion date December 30, 2023

Study information

Verified date June 2023
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Moms Are Worth It is a lifestyle behavior intervention study aims to prevent excessive gestational weight gain in overweight or obese pregnant women through promotion of the stress management, healthy eating, and physical activity. Eligible women will be randomly assigned to a usual care or an intervention plus usual care group. The intervention will last 20 weeks and will be delivered via weekly web and individual health coaching session (10 of them)


Description:

Current effective lifestyle behavior intervention studies aimed to prevent excessive gestational weight gain (EGWG) in overweight or obese pregnant women have limited practicality, scalability, and sustainability because of high participant burden and excessive cost for clinical practice. Also, prior studies paid little or no attention to motivation, emotion and cognition, all of which are critical to motivate and enable individuals to engage in healthy lifestyle behaviors and achieve positive health outcomes. A promising approach to prevent EGWG in overweight or obese pregnant women is through goal-oriented episodic future thinking (GOEFT). This pilot randomized controlled trial, aims to prevent EGWG in overweight or obese pregnant women. The proposed self-directed, web-based GOEFT intervention will focus on increasing motivation (autonomous motivation and self-efficacy) and improving emotion (emotion control and stress) and cognition (executive function, ExF), thus promoting healthy lifestyle behaviors. This will lead to prevention of EGWG and a reduced rate of gestational diabetes, gestational hypertension, cesarean delivery and fetal macrosomia. Our intervention will last 20 weeks (starting at 17 week-gestation). Participants (N = 90; 50% White, 50% minority) will be recruited and enrolled from prenatal care clinics at The Ohio State University Wexner Medical Center and be randomly assigned to our GOEFT intervention (n = 45) or usual care (n = 45). All participants will be assessed at baseline (<17 week-gestation, T1), 24-27 week-gestation (T2) and 35-37 week-gestation (T3). Specific aims are (1) to determine feasibility of the GOEFT intervention: recruitment, randomization, retention and intervention implementation, (2) to investigate the potential efficacy of the intervention on gestational weight gain and maternal and birth outcomes, (3) to investigate the potential impact of the intervention on lifestyle behaviors and (4) to investigate the potential impact of the intervention on motivation, emotion and cognition.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 90
Est. completion date December 30, 2023
Est. primary completion date January 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Participants must be pregnant women = 13 week-gestation with a single fetus as assessed by ultrasound. - Participants must also have self-reported pre-pregnancy body mass index (BMI) of 25.0-45.0 kg/m2 and height (height and weight to compute body mass index). - Ability to read and speak English, - Age of 18-45 years, - Access to a working smart phone with unlimited text messaging, - Access to internet, - Receipt of prenatal care from our collaborating clinics and plan to deliver the baby at The Ohio State University (OSU) Wexner Medical Center, - Resident of Franklin Count, - Committed to the 20-week intervention. Exclusion Criteria: - Self-reported history of = 3 miscarriages, - Planned termination of the pregnancy, - Diagnosed hypertension and/or type 1 or 2 diabetes, - History of or current diagnosis of an eating disorder, - Serious current physical disease (e.g., renal disease or cancer), - Past bariatric surgery, - Current or history of substance abuse in the past 6 months, - Current treatment for a serious psychological disorder (e.g., schizophrenia and bipolar disorder), - Contraindications to walking, - Consented women will become not eligible to participate in the study if they are not randomized by 16-week 6 days gestation. This is because the study intervention starts = 17 weeks gestation. - Women will become not ineligible for participation if they did not complete the baseline data.

Study Design


Intervention

Behavioral:
Goal-Oriented Episodic Future Thinking
Individuals in the intervention group will receive a 20-week web-based intervention and individual health coaching focused on stress management, healthy eating and physical activity.

Locations

Country Name City State
United States The Ohio State University Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Body weight Data extracted from electronic medical record Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Primary Change in Body weight Data extracted from electronic medical record 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Primary Change in Body weight Data extracted from electronic medical record Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Gestational Diabetes status Data extracted from electronic medical record 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Gestational Hypertension status Data extracted from electronic medical record 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Mode of Delivery Data extracted from electronic medical record 35-37 week-gestation (T3)
Secondary Newborn body weight Data extracted from electronic medical record. 35-37 week-gestation (T3)
Secondary Gestational age at birth Data extracted from electronic medical record.
The higher value, the higher gestational age
35-37 week-gestation (T3)
Secondary Change in Dietary Intake Behaviors Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants will complete 24-hour Recalls on two random days over a week. The variables of interest include calories, fat, sugary drinks, fruit and vegetable intakes. The higher scores indicate higher caloric, fat, sugary drinks, fruit and vegetable intakes. Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Dietary Intake Behaviors Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants will complete 24-hour Recalls on two random days over a week. The variables of interest include calories, fat, sugary drinks, fruit and vegetable intakes. The higher scores indicate higher caloric, fat, sugary drinks, fruit and vegetable intakes. 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Dietary Intake Behaviors Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants will complete 24-hour Recalls on two random days over a week. The variables of interest include calories, fat, sugary drinks, fruit and vegetable intakes. The higher scores indicate higher caloric, fat, sugary drinks, fruit and vegetable intakes. Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Physical Activity Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators will distribute the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (= 10 hours/per day). The higher score, the higher physical activity. Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Physical Activity Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators will distribute the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (= 10 hours/per day). The higher score, the higher physical activity. 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Physical Activity Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators will distribute the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (= 10 hours/per day). The higher score, the higher physical activity. Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Autonomous Motivation for Stress Management Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for stress management (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True
The investigators will sum 6 items to create a composite score, ranging from 6 to 42.
Higher scores indicate higher autonomous motivation for stress management.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Autonomous Motivation for Healthy Eating Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True
The investigators will sum 6 items to create a composite score, ranging from 6 to 42.
Higher scores indicate higher autonomous motivation for Healthy Eating.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Autonomous Motivation for Physical Activity Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True
The investigators will sum 6 items to create a composite score, ranging from 6 to 42.
Higher scores indicate higher autonomous motivation for Physical Activity.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Autonomous Motivation for Stress Management Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Stress Management (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True
The investigators will sum 6 items to create a composite score, ranging from 6 to 42.
Higher scores indicate higher autonomous motivation for Stress Management.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Autonomous Motivation for Healthy Eating Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True
The investigators will sum 6 items to create a composite score, ranging from 6 to 42.
Higher scores indicate higher autonomous motivation for Healthy Eating.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Autonomous Motivation for Physical Activity Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True
The investigators will sum 6 items to create a composite score, ranging from 6 to 42.
Higher scores indicate higher autonomous motivation for physical activity.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Autonomous Motivation for Stress Management Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for stress management (6 items)
Values are: 1 - Not At AllTrue, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True
The investigators will sum 6 items to create a composite score, ranging from 6 to 42.
Higher scores indicate higher autonomous motivation for stress managment.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Autonomous Motivation for Healthy Eating Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True
The investigators will sum 6 items to create a composite score, ranging from 6 to 42.
Higher scores indicate higher autonomous motivation for Healthy Eating
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Autonomous Motivation for Physical Activity Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True
The investigators will sum 6 items to create a composite score, ranging from 6 to 42.
Higher scores indicate higher autonomous motivation for Physical Activity.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Coping Self-efficacy Will be measured using a "Survey for Coping Self-efficacy" (10 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident
The investigators will sum 10 items to create a composite score, ranging from 10 to 40.
Higher scores indicate higher coping self-efficacy.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Coping Self-efficacy Will be measured using a "Survey for Coping Self-efficacy" (10 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident
The investigators will sum 10 items to create a composite score, ranging from 10 to 40.
Higher scores indicate higher coping self-efficacy.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Coping Self-efficacy Will be measured using a "Survey for Coping Self-efficacy" (10 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident
The investigators will sum 10 items to create a composite score, ranging from 10 to 40.
Higher scores indicate higher coping self-efficacy.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Healthy Eating Self-efficacy Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident.
The investigators will sum all 8 items to create a composite score, ranging from 8 to 32.
The higher score, the higher healthy eating self-efficacy.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Healthy Eating Self-efficacy Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident
The investigators will sum all 8 items to create a composite score, ranging from 8 to 32.
The higher score, the higher healthy eating self-efficacy.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Healthy Eating Self-efficacy Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident
The investigators will sum all 8 items to create a composite score, ranging from 8 to 32. The higher score, the higher healthy eating self-efficacy.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Physical Activity Self-efficacy Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity.
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident
The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Physical Activity Self-efficacy Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity.
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident
The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Physical Activity Self-efficacy Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity.
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident
The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Emotion Regulation Will be measured using the Emotion Regulation Questionnaire (10 items) that assess emotion regulatory process using reappraisal, suppression and regulating negative emotion. The questionnaire has 2 subscales: reappraisal (6 items, items 1-6) and suppression (4 items, items 7-10, 4 )
Values are: 1 - Strongly Disagree, 2 - Mostly Disagree, 3 - Somewhat Disagree, 4 - Neither Agree or Disagree, 5 - Somewhat Agree, 6 - Mostly Agree, 7 - Strongly Agree
The investigators will sum 6 items to create a composite score for reappraisal, ranging from 6 to 42.
The higher score, the higher appraisal.
The investigators will sum 4 items to create a composite score for suppression, ranging from 4 to 28.
The higher score, the higher suppression.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Emotion Regulation Will be measured using the Emotion Regulation Questionnaire (10 items) that assess emotion regulatory process using reappraisal, suppression and regulating negative emotion. The questionnaire has 2 subscales: reappraisal (6 items, items 1-6) and suppression (4 items, items 7-10, 4 )
Values are: 1 - Strongly Disagree, 2 - Mostly Disagree, 3 - Somewhat Disagree, 4 - Neither Agree or Disagree, 5 - Somewhat Agree, 6 - Mostly Agree, 7 - Strongly Agree
The investigators will sum 6 items to create a composite score for reappraisal, ranging from 6 to 42.
The higher score, the higher appraisal.
The investigators will sum 4 items to create a composite score for suppression, ranging from 4 to 28.
The higher score, the higher suppression.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Emotion Regulation Will be measured using the Emotion Regulation Questionnaire (10 items) that assess emotion regulatory process using reappraisal, suppression and regulating negative emotion. The questionnaire has 2 subscales: reappraisal (6 items, items 1-6) and suppression (4 items, items 7-10, 4 )
Values are: 1 - Strongly Disagree, 2 - Mostly Disagree, 3 - Somewhat Disagree, 4 - Neither Agree or Disagree, 5 - Somewhat Agree, 6 - Mostly Agree, 7 - Strongly Agree
The investigators will sum 6 items to create a composite score for reappraisal, ranging from 6 to 42.
The higher score, the higher appraisal.
The investigators will sum 4 items to create a composite score for suppression, ranging from 4 to 28.
The higher score, the higher suppression.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Perceived Stress Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful.
Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often
The investigators will sum 10 items to create a composite score, ranging from 0 to 40.
The higher score, the higher levels of perceived stress.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Perceived Stress Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful.
Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often
The investigators will sum 10 items to create a composite score, ranging from 0 to 40.
The higher score, the higher levels of perceived stress.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Perceived Stress Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful.
Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often
The investigators will sum 10 items to create a composite score, ranging from 0 to 40.
The higher score, the higher levels of perceived stress.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Change in Executive Function Will be measured using The Behavior Rating Inventory of Executive Function-Adults (BRIEF-A, 75 items). This survey measures an adult's executive function in her everyday environment: for example, inhibitory control, self-monitoring, plan/organization, and organization of materials.
Values are: 0 - Never, 1 - Sometimes, 2 - Often
The investigators will sum 75 items to create a composite score, ranging from 0 to 150.
The higher score, the lower executive function.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Secondary Change in Executive Function Will be measured using The Behavior Rating Inventory of Executive Function-Adults (BRIEF-A, 75 items). This survey measures an adult's executive function in her everyday environment: for example, inhibitory control, self-monitoring, plan/organization, and organization of materials.
Values are: 0 - Never, 1 - Sometimes, 2 - Often
The investigators will sum 75 items to create a composite score, ranging from 0 to 150.
The higher score, the lower executive function.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Secondary Change in Executive Function Will be measured using The Behavior Rating Inventory of Executive Function-Adults (BRIEF-A, 75 items). This survey measures an adult's executive function in her everyday environment: for example, inhibitory control, self-monitoring, plan/organization, and organization of materials.
Values are: 0 - Never, 1 - Sometimes, 2 - Often
The investigators will sum 75 items to create a composite score, ranging from 0 to 150.
The higher score, the lower executive function.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Acceptability Investigators will ask participants to evaluate the following: the usefulness (12 items) and satisfaction (12 items) of each intervention component.
Values are: 1 - not useful at all/not satisfy at all, 2, 3, 4 - very useful/very satisfy.
The investigators will sum the 12 items to create a composite score, ranging from 12 to 48.
The higher the score, the higher acceptability.
35-37 week-gestation (T3)
Secondary Process evaluation Investigators will use 8 items to conduct process evaluation. Investigators will ask all study participants' receipt of stress or emotion management, healthy eating, and physical activity counseling from their clinicians, midwifes and dietitians (Yes = 1/No =0). If yes, they will be asked about the frequency and length. Participants will also be asked if they have joined/received other programs to manage stress better, eat healthier, and be more physically active.
The investigators will sum 8 items to create a composite score, ranging from 0 to 8). The higher score, the more consultation received from clinicians, midwifes and dietitians.
35-37 week-gestation (T3)
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2